Synmosa Biopharma Corporation (TPEX:4114)

Synmosa Biopharma Revenue

Synmosa Biopharma had revenue of 1.61B TWD in the quarter ending June 30, 2025, with 21.00% growth. This brings the company's revenue in the last twelve months to 6.00B, up 15.61% year-over-year. In the year 2024, Synmosa Biopharma had annual revenue of 5.55B with 7.96% growth.

• Revenue (ttm): 6.00B
• Revenue Growth: +15.61%
• P/S Ratio: 3.02
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 18.10B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	5.55B	409.05M	7.96%
Dec 31, 2023	5.14B	754.13M	17.19%
Dec 31, 2022	4.39B	1.15B	35.59%
Dec 31, 2021	3.23B	196.67M	6.47%
Dec 31, 2020	3.04B	358.32M	13.37%